Last edition
News about "Ipsen"
Ipsen and Skyhawk Therapeutics to Work on RNA Targeting Research in Rare Neurological Diseases
Ipsen has signed an exclusive worldwide collaboration with Skyhawk Therapeutics to discover and develop novel small molecules that modulate RNA for rare neurological diseases.
Ipsen | 22/04/2024 | By Aishwarya | 142
Biopharmaceutical company Ipsen unveils 52 M Euro expansion plan
The investment is aimed at boosting medicine and ingredient production in cancer and rare disease space
Ipsen | 28/09/2022 | By Sudeep Soparkar | 507
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy